These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 34078163)

  • 21. Education, APOE ε4, and Cognition in Individuals with Subjective Cognitive Decline with Worry in the SILCODE Study.
    Chen G; Lin L; Yang K; Han Y
    Curr Alzheimer Res; 2021; 18(6):492-498. PubMed ID: 34598665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. APOE epsilon4 genotype and longitudinal changes in cerebral blood flow in normal aging.
    Thambisetty M; Beason-Held L; An Y; Kraut MA; Resnick SM
    Arch Neurol; 2010 Jan; 67(1):93-8. PubMed ID: 20065135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential Aging Trajectories of Modulation of Activation to Cognitive Challenge in APOE ε4 Groups: Reduced Modulation Predicts Poorer Cognitive Performance.
    Foster CM; Kennedy KM; Rodrigue KM
    J Neurosci; 2017 Jul; 37(29):6894-6901. PubMed ID: 28652414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential effects of the APOE genotype on brain function across the lifespan.
    Filippini N; Ebmeier KP; MacIntosh BJ; Trachtenberg AJ; Frisoni GB; Wilcock GK; Beckmann CF; Smith SM; Matthews PM; Mackay CE
    Neuroimage; 2011 Jan; 54(1):602-10. PubMed ID: 20705142
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Mirza SS; Saeed U; Knight J; Ramirez J; Stuss DT; Keith J; Nestor SM; Yu D; Swardfager W; Rogaeva E; St George Hyslop P; Black SE; Masellis M;
    Neurology; 2019 Nov; 93(19):e1807-e1819. PubMed ID: 31575706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regional hyperperfusion in cognitively normal
    McKiernan EF; Mak E; Dounavi ME; Wells K; Ritchie C; Williams G; Su L; O'Brien J
    J Neurol Neurosurg Psychiatry; 2020 Aug; 91(8):861-866. PubMed ID: 32586852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regional atrophy of transcallosal prefrontal connections in cognitively normal APOE epsilon4 carriers.
    Filippini N; Zarei M; Beckmann CF; Galluzzi S; Borsci G; Testa C; Bonetti M; Beltramello A; Ghidoni R; Benussi L; Binetti G; Frisoni GB
    J Magn Reson Imaging; 2009 May; 29(5):1021-6. PubMed ID: 19388128
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mapping the effect of APOE epsilon4 on gray matter loss in Alzheimer's disease in vivo.
    Pievani M; Rasser PE; Galluzzi S; Benussi L; Ghidoni R; Sabattoli F; Bonetti M; Binetti G; Thompson PM; Frisoni GB
    Neuroimage; 2009 May; 45(4):1090-8. PubMed ID: 19349226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lower cerebral blood flow is associated with impairment in multiple cognitive domains in Alzheimer's disease.
    Leeuwis AE; Benedictus MR; Kuijer JPA; Binnewijzend MAA; Hooghiemstra AM; Verfaillie SCJ; Koene T; Scheltens P; Barkhof F; Prins ND; van der Flier WM
    Alzheimers Dement; 2017 May; 13(5):531-540. PubMed ID: 27693109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease.
    Mata IF; Leverenz JB; Weintraub D; Trojanowski JQ; Hurtig HI; Van Deerlin VM; Ritz B; Rausch R; Rhodes SL; Factor SA; Wood-Siverio C; Quinn JF; Chung KA; Peterson AL; Espay AJ; Revilla FJ; Devoto J; Hu SC; Cholerton BA; Wan JY; Montine TJ; Edwards KL; Zabetian CP
    JAMA Neurol; 2014 Nov; 71(11):1405-12. PubMed ID: 25178429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aβ amyloid, cognition, and APOE genotype in healthy older adults.
    Lim YY; Ellis KA; Ames D; Darby D; Harrington K; Martins RN; Masters CL; Rowe C; Savage G; Szoeke C; Villemagne VL; Maruff P;
    Alzheimers Dement; 2013 Sep; 9(5):538-45. PubMed ID: 23159043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Components of the choline oxidation pathway modify the association between the apolipoprotein ε4 gene variant and cognitive decline in patients with dementia.
    Hildre AS; Solvang SH; Aarsland D; Midtun Ø; McCann A; Ervik AO; Nygård O; Ueland PM; Nordrehaug JE; Giil LM
    Brain Res; 2020 Jan; 1726():146519. PubMed ID: 31654640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlations between apolipoprotein E epsilon4 gene dose and whole brain atrophy rates.
    Chen K; Reiman EM; Alexander GE; Caselli RJ; Gerkin R; Bandy D; Domb A; Osborne D; Fox N; Crum WR; Saunders AM; Hardy J
    Am J Psychiatry; 2007 Jun; 164(6):916-21. PubMed ID: 17541051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apolipoprotein E genotype and cerebrovascular alterations can influence conversion to dementia in patients with mild cognitive impairment.
    Viticchi G; Falsetti L; Vernieri F; Altamura C; Altavilla R; Luzzi S; Bartolini M; Provinciali L; Silvestrini M
    J Alzheimers Dis; 2014; 41(2):401-10. PubMed ID: 24625799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apolipoprotein E ε4 Modulates Cognitive Profiles, Hippocampal Volume, and Resting-State Functional Connectivity in Alzheimer's Disease.
    Wang X; Wang J; He Y; Li H; Yuan H; Evans A; Yu X; He Y; Wang H
    J Alzheimers Dis; 2015; 45(3):781-95. PubMed ID: 25624419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebrovascular resistance: effects on cognitive decline, cortical atrophy, and progression to dementia.
    Yew B; Nation DA;
    Brain; 2017 Jul; 140(7):1987-2001. PubMed ID: 28575149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Convergent and divergent effects of apolipoprotein E ε4 and ε2 alleles on amygdala functional networks in nondemented older adults.
    Gong L; Shu H; He C; Ye Q; Bai F; Xie C; Zhang Z
    Neurobiol Aging; 2017 Jun; 54():31-39. PubMed ID: 28319835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Greater tau load and reduced cortical thickness in APOE ε4-negative Alzheimer's disease: a cohort study.
    Mattsson N; Ossenkoppele R; Smith R; Strandberg O; Ohlsson T; Jögi J; Palmqvist S; Stomrud E; Hansson O
    Alzheimers Res Ther; 2018 Aug; 10(1):77. PubMed ID: 30086796
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lower cerebral oxygen utilization is associated with Alzheimer's disease-related neurodegeneration and poorer cognitive performance among apolipoprotein E ε4 carriers.
    Robb WH; Khan OA; Ahmed HA; Li J; Moore EE; Cambronero FE; Pechman KR; Liu D; Gifford KA; Landman BA; Donahue MJ; Hohman TJ; Jefferson AL
    J Cereb Blood Flow Metab; 2022 Apr; 42(4):642-655. PubMed ID: 34743630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apolipoprotein epsilon4 and neuropsychological performance in Alzheimer's disease and vascular dementia.
    McGuinness B; Carson R; Barrett SL; Craig D; Passmore AP
    Neurosci Lett; 2010 Oct; 483(1):62-6. PubMed ID: 20678545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.